Clinical Studies| Volume 20, ISSUE 1, P80-87, January 1998

Comparison of the skin irritation potential of two testosterone transdermal systems: an investigational system and a marketed product

      This paper is only available as a PDF. To read, Please Download here.


      Effective transdermal therapy provides controlled release of the appropriate amount of a therapeutic agent while minimizing local irritation. Transdermal administration of testosterone has the potential to produce skin irritation. This open-label, randomized, 14-day, outpatient study compared the skin irritation of an investigational testosterone transdermal system (System I) with that of a marketed testosterone transdermal system (System II) in healthy men. In Part 1 of the study, System I was applied 10 times over 14 days to the same skin site on the backs of 26 healthy men. In Part 2, the skin irritation resulting from daily application of Systems I and II was assessed over 14 days in 17 men less than 65 years of age and 16 men 65 years of age or older. At the end of Part 1 of the study, 65.4% of the subjects experienced no erythema, 15.4% of subjects had faint erythema, and 19.2% had moderately intense erythema immediately after System I removal. At the completion of Part 2, none of the System I application sites were assessed as having moderately intense erythema, whereas one third (33.3%) of System II application sites demonstrated moderately intense erythema. There were no differences in erythema rates between younger and older subjects with either transdermal system. During this study, repeated application of System I to the same skin site resulted in acceptable noncumulative irritation, suggesting that application-site rotation may not be necessary. A comparison of the two systems demonstrates that System I results in significantly less application-site irritation than does System II and that older men do not have a higher rate of skin reactions.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bhasin S
        • Bremner WJ
        Emerging issues in androgen replacement therapy.
        J Clin Endocrinol Metab. 1997; 82: 3-8
        • Behre HM
        • Kliesch S
        • Leifke E
        • et al.
        Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
        J Clin Endocrinol Metab. 1997; 82: 2386-2390
        • Place VA
        • Atkinson L
        • Prather DA
        • et al.
        Transdermal testosterone replacement through genital skin.
        in: Nieschlag E Behre HM Testosterone: Action, Deficiency, Substitution. Springer-Verlag, Berlin1990: 165-181
        • Arver S
        • Dobs AS
        • Meikle AW
        • et al.
        Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system.
        J Urol. 1996; 155: 1604-1608
        • Cofrancesco J
        • Dobs AS
        Transdermal testosterone delivery systems.
        Endocrinologist. 1996; 6: 207-213
        • Jordan Jr, WP
        Allergy and topical irritation associated with transdermal testosterone administration: A comparison of scrotal and nonscrotal transdermal systems.
        Am J Contact Dermatitis. 1997; 8: 108-113
        • Davis Jr, GF
        • Winter Jr, L
        Cumulative irritation study of placebo transdermal estrogen patches.
        Curr Ther Res. 1987; 42: 712-719
      1. Physicians' Desk Reference®. Medical Economics Company, Inc, Montvale, NJ1998: 2796-2798
      2. Physicians' Desk Reference®. Medical Economics Company, Inc, Montvale, NJ1998: 1847-1850
      3. Physicians' Desk Reference®. Medical Economics Company, Inc, Montvale, NJ1998: 710-712
        • Stotts J
        • Ely WJ
        Induction of human skin sensitization to ethanol.
        J Invest Dermatol. 1977; 69: 219-222